clear search
Search
Search Suggestions
Recent searches Clear History
Contact Us
Allergen Encyclopedia
Table of Contents

Whole Allergen

g3 Cocksfoot

g3 Cocksfoot Scientific Information

Type:

Whole Allergen

Display Name:

Cocksfoot

Route of Exposure:

Inhalation

Family:

Poaceae (Gramineae)

Species:

Dactylis glomerata

Latin Name:

Dactylis glomerata

Other Names:

Cocksfoot grass, Cock's foot grass, Cock's-foot, Orchard Grass, Orchardgrass

Summary

Cocksfoot (Dactylis glomerata) is a cool-season grass and one of the most common grasses, portraying its wide use as forage and hay. Cocksfoot very well abides sensitive to extreme conditions of temperature and adapts to the Mediterranean climate. The most common subspecies of cocksfoot accepted includes D. glomerata – ssp. glomerata and ssp. lobata (Drejer) H. Lindb. Cocksfoot belongs to the order: Cyperales; Family: Poaceae; Genus: Dactylis and Species: Dactylis glomerata. The size range of cocksfoot pollen generally varies between 10 microns to 10 nanometers. Pollen exposure of cocksfoot may cause hay fever, asthma, allergic conjunctivitis, or atopic dermatitis. In the US, 75% of the population is exposed to cocksfoot. Allergic rhinitis is a major risk factor for the development of asthma. According to a study conducted in Germany, sensitivity to allergic pollens was observed in 19.7% of patients and the allergic rhinitis diagnosis was present in 8.7% of the population. Out of the allergenic components, Dac g 4, is a major 60 kDa protein. Dac g 4 reports allergenicity, as the majority of plasma samples demonstrated IgE binding to Dac g 4 on IEF-immunoprint. Cocksfoot pollens can be cross-reactive with other pollen allergens such as timothy grass and ryegrass and with wheat. Specific allergen immunotherapy may include administration of the allergen extract, either subcutaneously or sublingually along with other routes

Allergen

Nature

Cocksfoot (Dactylis glomerata) is a cool-season grass and one of the most common grasses, portraying its wide use as forage and hay (1). It is non-rhizomatous and grows up to 150 cm in length with a huge root system. Cocksfoot further demonstrates its property of being erect with an 8-20 cm long flower head. It has several tight spikelet clusters on one side (1) with 5 florets per spikelet (2). Cocksfoot flowers in the middle of the spring season, however, the rainy season can increase the flowering period, especially in Mediterranean areas (3).

Habitat

Cocksfoot grows well in hedgerows, meadows, pastures and rough grassland around the lowlands. It very well abides sensitive to extreme conditions of temperature, wind and precipitation; however, very wet conditions are not tolerated by cocksfoot. Heathlands, open woodlands, forests, riparian habitats, freshwater wetlands and coastal environs are the habitats of cocksfoot in Australia (CABI, 2019).  As per recent literature, it is found that cocksfoot is very well adapted to the Mediterranean climate.(4)

Taxonomy

Among a wide variety of subspecies according to ITIS, the most common subspecies (ssp) accepted includes D. glomerata – ssp. glomerata and ssp. lobata (Drejer) H. Lindb. (5).

Taxonomic tree of Cocksfoot  (5,6)  
Domain Eukaryota
Kingdom Plantae
Phylum Spermatophyta
Subphylum Angiospermae
Class Monocotyledonae 
Order Cyperales
Family Poaceae
Genus Dactylis
Species Dactylis glomerata

Tissue

Grass pollen grains are spheroidal to sub oblate in shape with mean grain size is around 35 x 40 µm. It has a single circular pore surrounded by a distinct thickening of the outer and inner wall (annulus) (7).

The size range of cocksfoot pollen generally varies between 10 microns to 10 nanometers, which is characterized by a thin exine with minimal ornamentation visible under transmitted light (8).

According to a study conducted, the use of Airyscan demonstrated distinguishing larger features (1–3 cycles/mm, or 1,000–333 nm in size), and the SR-SIM was able to detect smaller features (6–8 cycles/mm, or 166–125 nm in size) (8).

Epidemiology

Worldwide distribution

Cocksfoot is of the most widespread genera to cause grass pollen allergy in the Northern Hemisphere, along with other species (7). An alarming rise in the seasonal pollen-associated asthma and hay fever has been observed in Australia, wherein, around 10% of adults and 30% of children are identified with respiratory disease. (7)

Within the US, 75% of the population is exposed to cocksfoot. Noticeable exposure patterns are observed based on varied geographic regions, for example, 43% of the population across the southeastern US was exposed to cocksfoot. Moreover, heterogeneous exposure to cocksfoot in the Northwestern US and East Central region was noted with 94% and 98%, respectively. (9)

Risk factors

Globally, aeroallergens play a vital role in causing pollinosis. The airborne pollen aims at the respiratory system directly, which results in hypersensitivity disorders in genetically compromised patients. However, it causes late hypersensitivity in patients with allergic rhinitis, allergic alveolitis, asthma, atopic dermatitis, etc. (10)

The pollens belonging to the Gramineae family are at the top list of causing allergic diseases. According to a study conducted in Germany, a total of 1101 children (aged 8-11 years) showed sensitivity to pollens. Sensitivity was observed in 19.7% of patients and the allergic rhinitis diagnosis was present in 8.7% of the population. Another study performed in adults in Austria, revealed that the most affected age group by the Gramineae family’s pollen allergy was 21-30 years wherein, 17% of healthy individuals were sensitized to grass.(11)

Environmental Characteristics

Worldwide distribution

Cocksfoot is reported to be native to Europe, North Africa, and parts of Asia. It is also produced throughout much of the world, including Northwestern Europe, Australia, New Zealand, Japan, and the northeastern portion of the United States and the Pacific Northwest (12).

Environmental requirements

Cocksfoot requires rich or moderately fertile soils with sufficient water (30 cm or more rainfall a year) in North America. Further, high elevation (1500 to 1900 m) works well for the species in the western USA and Canada. In Kashmir and western Tibet, it grows in the forest and opens grassland at an altitude of 1800-3600m, whereas, in France and North Africa ascends to 2100m and 2400m, respectively. Cocksfoot grows in the soil with a suitable pH of in the range from 5.5 to 8.0. (13)

Route of Exposure

Main

Airway Inhalation

The main route of exposure for cocksfoot pollen is through inhaling which in relay cause hypersensitivity response in cocksfoot pollen-allergic patients. Patients exposed to cocksfoot through inhalation in the airways are likely to suffer from allergic rhinitis, asthma, conjunctivitis, atopic dermatitis, etc (10, 14, 15).

Clinical Relevance

Allergic rhinitis

Patients with exposed grass pollens exhibit rhinorrhea, nasal obstruction, nasal itching and sneezing. (14) The cytokine levels are reported to increase in nasal secretions in patients with allergic rhinitis after a trigger by an antigen. The elevated levels are reported to play a role in diagnosing the inhalant allergens. According to a study, exposure of cocksfoot resulted in elevated levels of eosinophils, interleukin (IL) 5, IL-6, IL-13, and macrophage inflammatory protein 1β in patients with allergic rhinitis. (16)

Specific chromosome regions are reported to be linked with seasonal allergic rhinitis. A study was conducted, in a genomic search including 48 Japanese families (188 members) with at least 2 siblings with AR due to cocksfoot, the associated chromosomal regions observed were 1p36.2, 4q13.3 y 9q34.3 along with a weak linkage to 5q33.1 (17)

Asthma

Allergic rhinitis is a major risk factor for the development of asthma. (15)

Conjunctivitis

Exposure of pollen allergens to the conjunctiva results in itching, injection, and tearing. (15)

Allergic rhinoconjunctivitis is associated with morbidity and further, it also impairs quality of life. (15) Allergen immunotherapy, including extracts of cocksfoot along with other extracts, is efficacious in improving symptom, medication, and combined symptom and medication scores in patients with ongoing treatment pertaining to allergic rhinoconjunctivitis. (15)

Atopic Dermatitis

Exposure to cocksfoot is reported to worsen the existing condition of atopic dermatitis. (18) A first controlled double-blind study was conducted in 34 patients with atopic dermatitis. The exposure of cocksfoot resulted in worsening of the cutaneous symptoms. A flare-up in eczema was observed on the air-exposed skin areas as compared with the covered skin areas. Serum analysis, using the biomarkers such as chemokine C-C motif ligand 17 (CCL17), chemokine C-C motif ligand 22 (CCL22), and interleukin (IL)-4 serum, is used to determine the immune response induced by the exposure of grass pollen. Patients exposed to cocksfoot showed a noticeable elevation of CCL17, CCL22, and IL-4 serum levels. (18)

Prevention and Therapy

Allergen immunotherapy

Specific allergen immunotherapy includes administration of the allergen extract, either subcutaneously or sublingually to decrease the need for other medications. The other options available include via oral, intranasal, epicutaneous, intra-dermal, or intra-lymphatic route. (19)

Prevention strategies

Avoidance

A randomized, double-blind, placebo-controlled, partial-crossover study conducted in 146 patients with seasonal allergic rhinitis exposed to cocksfoot pollens demonstrated a reduction in seasonal allergic rhinitis symptoms with an oral antagonist and thus increasing the effectiveness of the therapy. (20) Controlled exposure of the cocksfoot can help in the reduction of atopic dermatitis associated symptoms. (18)

Molecular Aspects

Allergenic molecules

In the cocksfoot plant, a list of allergenic components is inked which are as follows:

  • Dac g 1. Beta-expansin, (32kDa): Serum IgE antibodies of 95% of human patients sensitive to cocksfoot pollen can be recognized by Dac g 1, as revealed by the nitrocellulose immunoprint approach. (21)
  • Dac g 2, (11 kDa): The human IgE antibodies in 33% of sera randomly selected from grass-sensitive individuals was helpful in identifying the recombinant Dac g 2 and in 67% of sera from patients on immunotherapy with grass pollen immunotherapy. (21, 22)
  • Dac g 3, (14 kDa protein): Dac g 3 is recognized by more than 60% of sera from cocksfoot pollen-allergic individuals. IgE binding and initiation of histamine-release of rDac g 3 is noted. (21)
  • Dac g 4, a major 60 kDa protein: 23 out of 26 plasma samples demonstrated IgE binding to Dac g 4 on IEF-immunoprint, after a selection done on the of high IgG4 levels against cocksfoot pollen extract. (21)
  • Dac g 5, (16-17). 25/28 kDa: Serum analysis of grass sensitized patients, IgE binding to purified Dac g 5 was observed in immunoblot. (21)

Cross-reactivity

According to a study the data reported a high percentage of cross-reactivity between the allergens from cocksfoot, timothy grass and ryegrass that were tested in the population compared to the mixture of grass pollens and to single pollens using the sera of patients. (23) It is also noted to be cross-reactive with wheat pollens (24).

Compiled By

Author: Turacoz Healthcare Solutions

Reviewer: Dr. Christian Fischer

 

Last reviewed: November 2020

References
  1. Mir NH. Dactylis glomerata L. (Cock’s Foot/Orchard Grass): A Potential Temperate Forage Grass for Cultivation in North Western Himalaya. Advances in Research 15(5): 1-10, 2018. 2018.
  2. Zahid MI. A Thesis Presented in Partial Fulfilment of the Requirements for the Degree of Master of Agricultural Science at Massey University Palmerston North New Zealand. 1996.
  3. Tormo-Molina. Flower production and phenology in Dactylis glomerata. Aerobiologia 31, 469–479 (2015). 2015.
  4. Zhouri L, Kallida R, Shaimi N, Barre P, Volaire F, Gaboun F, et al. Evaluation of cocksfoot (Dactylis glomerata L.) population for drought survival and behavior. Saudi J Biol Sci. 2019;26(1):49-56.
  5. ITIS. Dactylis glomerata  L 2020 [22-09-2020]. Available from: https://www.itis.gov/servlet/SingleRpt/SingleRpt?search_topic=TSN&search_value=193446#null.
  6. Kleine-Tebbe J. GRASS POLLEN ALLERGENS: Global atlas oF allergy 2015; 2015. Available from: http://dgaki.de/wp-content/uploads/2015/05/GRASS-ALLERGENS-Chapter-3g-in-GlobalAtlasofAllergy-EAACI-2014.pdf.
  7. Garcia-Mozo H. Poaceae pollen as the leading aeroallergen worldwide: A review. Allergy. 2017;72(12):1849-58.
  8. Sivaguru M, Urban MA, Fried G, Wesseln CJ, Mander L, Punyasena SW. Comparative performance of airyscan and structured illumination superresolution microscopy in the study of the surface texture and 3D shape of pollen. Microsc Res Tech. 2018;81(2):101-14.
  9. Lankow RK. Grass Pollen Exposure in the Continental United States: Species Prevalence and Population Patterns. J ALLERGY CLIN IMMUNOL 2015.
  10. Singh AB, Mathur C. An aerobiological perspective in allergy and asthma. Asia Pac Allergy. 2012;2(3):210-22.
  11. Nikoleta K. Pollinosis caused by the representatives of Gramineae family. 2020.
  12. Putnam. Forage Crops. Encyclopedia of Agriculture and Food Systems, 2014. 2014.
  13. CABI. Dactylis glomerata (cocksfoot) 2019 [22-09-2020]. Available from: https://www.cabi.org/isc/datasheet/17618.
  14. Yavuz ST, Siebert S, Akin O, Arslan M, Civelek E, Bagci S. Perinatal risk factors for asthma in children with allergic rhinitis and grass pollen sensitization. Allergy Asthma Proc. 2018;39(3):1-7.
  15. Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. Allergy. 2017;72(11):1597-631.
  16. Badorrek P, Muller M, Koch W, Hohlfeld JM, Krug N. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure. Ann Allergy Asthma Immunol. 2017;118(3):290-7.
  17. Davila I, Mullol J, Ferrer M, Bartra J, del Cuvillo A, Montoro J, et al. Genetic aspects of allergic rhinitis. J Investig Allergol Clin Immunol. 2009;19 Suppl 1:25-31.
  18. Werfel T, Heratizadeh A, Niebuhr M, Kapp A, Roesner LM, Karch A, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol. 2015;136(1):96-103 e9.
  19. Muraro A. EAACI Guidelines Allergen Immunotherapy Guidelines 2017. Available from: http://www.eaaci.org/documents/AIT_Guidelines-web_version.pdf.
  20. Krug N, Gupta A, Badorrek P, Koenen R, Mueller M, Pivovarova A, et al. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 2014;133(2):414-9.
  21. WHO/IUIS. ALLERGEN NOMENCLATURE WHO/IUIS Allergen Nomenclature Sub-Committee 2019 [21-09-2020]. Available from: http://www.allergen.org/search.php?Species=Dactylis%20glomerata.
  22. Roberts AM, Van Ree R, Cardy SM, Bevan LJ, Walker MR. Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy. Immunology. 1992;76(3):389-96.
  23. Aleksic I. The importance of cross-reactivity in grass pollen allergy. Archives of Biological Sciences 2014.
  24. Gangl K. Marker Allergens and Panallergens in Tree and Grass Pollen Allergy. Molecular Allergy Diagnostics. 2017.